    <SEC-DOCUMENT>0001641172-25-004594-index.html : 20250414
    <SEC-HEADER>0001641172-25-004594.hdr.sgml : 20250414
    <ACCEPTANCE-DATETIME>20250414170517
    ACCESSION NUMBER:		0001641172-25-004594
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250414
    DATE AS OF CHANGE:		20250414
    EFFECTIVENESS DATE:		20250414

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Ernexa Therapeutics Inc.
    		CENTRAL INDEX KEY:			0000748592
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				311103425
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-11460
    		FILM NUMBER:		25836664

    	BUSINESS ADDRESS:
    		STREET 1:		1035 CAMBRIDGE STREET
    		STREET 2:		SUITE 18A
    		CITY:			CAMBRIDGE
    		STATE:			MA
    		ZIP:			02141
    		BUSINESS PHONE:		(617) 798-6700

    	MAIL ADDRESS:
    		STREET 1:		10531 4S COMMONS DRIVE
    		STREET 2:		SUITE 166-550
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92127

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Eterna Therapeutics Inc.
    		DATE OF NAME CHANGE:	20221017

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Brooklyn ImmunoTherapeutics, Inc.
    		DATE OF NAME CHANGE:	20210325

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	NTN BUZZTIME INC
    		DATE OF NAME CHANGE:	20051230
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>formars.pdf
    <TEXT>
    Document 1 - file: formars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>